Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07213674
PHASE3

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Sponsor: Amgen

View on ClinicalTrials.gov

Summary

The primary objective of this study is to compare overall survival (OS) in participants receiving xaluritamig plus abiraterone against investigator's choice (docetaxel, cabazitaxel, or abiraterone).

Official title: A Phase 3, Open-label, Multicenter, Randomized Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

Key Details

Gender

MALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

750

Start Date

2025-11-28

Completion Date

2032-08-30

Last Updated

2026-10-20

Healthy Volunteers

No

Interventions

DRUG

Xaluritamig

Xaluritamig will be administered IV.

DRUG

Abiraterone acetate

Abiraterone acetate will be administered orally.

DRUG

Docetaxel

Docetaxel will be administered IV.

DRUG

Cabazitaxel

Cabazitaxel will be administered IV.

Locations (159)

City of Hope Cancer Center Phoenix

Goodyear, Arizona, United States

University of Arizona Cancer Center

Tucson, Arizona, United States

City of Hope National Medical Center

Duarte, California, United States

City of Hope Orange County Lennar Foundation Cancer Center

Duarte, California, United States

Providence Saint Jude Medical Center

Fullerton, California, United States

University of California Los Angeles

Los Angeles, California, United States

University of California Irvine

Orange, California, United States

University of California San Francisco

San Francisco, California, United States

Providence Saint Johns Health Center

Santa Monica, California, United States

Rocky Mountain Cancer Centers

Denver, Colorado, United States

Hartford HealthCare Cancer Institute at Hartford Hospital

Hartford, Connecticut, United States

Medical Oncology Hematology Consultants Helen F Graham Cancer Center

Newark, Delaware, United States

Moffitt Cancer Center

Tampa, Florida, United States

City of Hope Atlanta

Newnan, Georgia, United States

University of Illinois Chicago

Chicago, Illinois, United States

Cancer Care Specialists of Illinois

Decatur, Illinois, United States

Midwestern Regional Medical Center dba City of Hope Chicago

Zion, Illinois, United States

University of Kansas Medical Center

Westwood, Kansas, United States

University of Louisville Health - James Graham Brown Cancer Center

Louisville, Kentucky, United States

Norton Cancer Institute

Louisville, Kentucky, United States

University of Maryland Greenebaum Cancer Center

Baltimore, Maryland, United States

Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center

Baltimore, Maryland, United States

Barbara Ann Karmanos Cancer Institute

Lansing, Michigan, United States

Minnesota Oncology Hematology PA

Minneapolis, Minnesota, United States

University of Minnesota Medical Center Fairview

Minneapolis, Minnesota, United States

Hematology Oncology Association of Central New York

East Syracuse, New York, United States

Memorial Sloan Kettering Cancer Center

New York, New York, United States

Oncology Hematology Care Incorporated

Cincinnati, Ohio, United States

The Ohio State University

Columbus, Ohio, United States

Dayton Physicians LLC Dayton

Dayton, Ohio, United States

Hightower Clinical

Oklahoma City, Oklahoma, United States

Oregon Oncology Specialists

Salem, Oregon, United States

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States

South Texas Accelerated Research Therapeutics - Carolinas

Myrtle Beach, South Carolina, United States

Sarah Cannon Research Institute Oncology Partners

Nashville, Tennessee, United States

United States Oncology Regulatory Affairs Corporate Office

Nashville, Tennessee, United States

The Center for Cancer and Blood Disorders

Arlington, Texas, United States

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Renovatio Clinical

Houston, Texas, United States

Texas Oncology - Northeast Texas

Tyler, Texas, United States

US Oncology Research Investigational Products Center

Tyler, Texas, United States

University of Virginia Cancer Center

Charlottesville, Virginia, United States

Virginia Cancer Specialists PC

Leesburg, Virginia, United States

Bon Secours Cancer Institute at Saint Francis

Midlothian, Virginia, United States

Virginia Oncology Associates

Norfolk, Virginia, United States

Northwest Medical Specialties, PLLC

Tacoma, Washington, United States

Calvary Mater Newcastle Hospital

Waratah, New South Wales, Australia

Icon Cancer Care Wesley

Auchenflower, Queensland, Australia

Tasman Oncology Research

Southport, Queensland, Australia

Princess Alexandra Hospital

Woolloongabba, Queensland, Australia

Monash Medical Centre

Clayton, Victoria, Australia

Austin Health, Austin Hospital

East Melbourne, Victoria, Australia

Medizinische Universitaet Innsbruck

Innsbruck, Austria

Ordensklinikum Linz Elisabethinen

Linz, Austria

Universitaetsklinikum Sankt Poelten

Sankt Pölten, Austria

Krankenhaus der Barmherzigen Brueder Wien

Vienna, Austria

Universitaetsklinikum Allgemeines Krankenhaus Wien

Vienna, Austria

Universite Catholique de Louvain Cliniques Universitaires Saint Luc

Brussels, Belgium

Universitair Ziekenhuis Gent

Ghent, Belgium

Algemeen Ziekenhuis Groeninge - Campus Kennedylaan

Kortrijk, Belgium

Universitair Ziekenhuis Leuven - Campus Gasthuisberg

Leuven, Belgium

Centre Hospitalier Universitaire Dinant Godinne - Universite Catholique de Louvain Namur

Yvoir, Belgium

Sunnybrook Research Institute Sunnybrook Health Sciences Centre

Toronto, Ontario, Canada

Centre de Recherche du Centre Hospitalier de l Universite de Montreal

Montreal, Quebec, Canada

Sir Mortimer B Davis - Jewish General Hospital

Montreal, Quebec, Canada

CIUSSS de l Estrie CHUS Hopital Fleurimont

Sherbrooke, Quebec, Canada

Centre Hospitalier Universitaire de Bordeaux - Hopital Saint Andre

Bordeaux, France

Institut Bergonie

Bordeaux, France

Centre Regional Francois Baclesse

Caen, France

Centre Jean Perrin

Clermont-Ferrand, France

Clinique Victor Hugo - Centre Jean Bernard

Le Mans, France

Centre Leon Berard

Lyon, France

Centre Antoine Lacassagne

Nice, France

Groupe Hospitalier Paris Saint Joseph

Paris, France

Hopital Europeen Georges Pompidou

Paris, France

Centre Hospitalier Universitaire de Strasbourg - Hopital de Hautepierre

Strasbourg, France

Hopital Foch

Suresnes, France

Institut Universitaire du Cancer Toulouse Oncopole

Toulouse, France

Institut de Cancerologie de Lorraine

Vandœuvre-lès-Nancy, France

Gustave Roussy

Villejuif, France

Charite - Universitaetsmedizin Berlin, Campus Mitte

Berlin, Germany

Universitaetsklinikum Bonn

Bonn, Germany

Universitaetsklinikum Dresden

Dresden, Germany

Uniklinikum Erlangen

Erlangen, Germany

Universitaetsklinikum Essen

Essen, Germany

Universitaetsklinikum Hamburg Eppendorf

Hamburg, Germany

Universitaetsklinikum Heidelberg

Heidelberg, Germany

Universitaetsklinikum Jena

Jena, Germany

Universitaetsklinikum Schleswig-Holstein - Kiel

Kiel, Germany

Universitaetsklinikum Ulm

Ulm, Germany

Universitaetsklinikum Wuerzburg

Würzburg, Germany

University General Hospital of Alexandroupoli

Alexandroupoli, Greece

Henry Dunant Hospital Center

Athens, Greece

Alexandra Hospital

Athens, Greece

Attikon University Hospital

Athens, Greece

University Hospital of Heraklion

Heraklion - Crete, Greece

General Oncological Hospital of Kifisia Oi Agioi Anargyroi

Kifissia, Athens, Greece

Athens Medical Center S.A - Iatriko Amarousiou

Marousi, Greece

European Interbalkan Medical Center

Thessaloniki, Greece

Azienda Ospedaliero Universitaria Ospedali Riuniti di Foggia

Foggia, Italy

And 59 more locations on ClinicalTrials.gov